DXCM - 2 Reasons to Buy DexCom and 1 Reason to Sell
A struggling economy, rising interest rates, and negative results from high-profile corporations continue to drag the stock market down. And although medical device specialist DexCom (NASDAQ: DXCM) hasn't entirely escaped the bloodbath, the company has been doing much better in the past few months.
Now, investors want to know whether DexCom can continue riding that wave for a while -- and there are good reasons why it might. However, there is also at least one major worry with this healthcare company. Are its shares a buy? Let's briefly look at both sides of the argument.
For further details see:
2 Reasons to Buy DexCom, and 1 Reason to Sell